National Immunization Survey

National Immunization Survey
Name	National Immunization Survey
Established	1994
Agency	Centers for Disease Control and Prevention
Country	United States
Frequency	Continuous
Method	Telephone survey, vaccination record follow-up

National Immunization Survey The National Immunization Survey is a United States public health surveillance program that measures vaccination coverage among children and adolescents. It is administered by the Centers for Disease Control and Prevention and collaborates with state health departments, the National Center for Health Statistics, and academic partners to produce annual estimates used by policy makers and researchers. The survey informs programs such as Vaccines for Children Program and supports goals set by Healthy People 2020 and Healthy People 2030.

Overview

The survey collects immunization data for cohorts including children aged 19–35 months, adolescents aged 13–17 years, and young children in other age groups to estimate coverage for vaccines like measles–mumps–rubella and human papillomavirus. It links household interviews with provider-reported vaccination histories from pediatricians, family physicians, and clinic records to validate parent report and generate national, state, and local coverage estimates. Outputs are used by the Advisory Committee on Immunization Practices, state health departments such as the New York State Department of Health and California Department of Public Health, and international bodies including the World Health Organization for comparative analyses.

Methodology

The design uses a stratified, random-digit-dial (RDD) sample incorporating both landline and cellular telephone frames, with later integration of address-based sampling and electronic record linkage in pilot phases. Interviewers collect demographic variables such as age, sex, and race/ethnicity and request consent to contact identified vaccination providers. Medical history verification relies on provider-reported immunization records from settings like community health centers, private practice offices, and hospital vaccination clinics. Weighting procedures adjust for nonresponse and sampling design using techniques aligned with standards from the National Center for Health Statistics and methods taught at institutions like Johns Hopkins University and Harvard School of Public Health.

History and Development

Established in 1994 to monitor progress toward elimination of vaccine-preventable diseases, the program evolved through methodological updates responding to changes in telephone use and vaccine schedules. Early administration involved primarily landline RDD and collaboration with the Morbidity and Mortality Weekly Report for dissemination; later innovations incorporated cell-phone sampling after deliberations by panels including experts from American Academy of Pediatrics and Association of Public Health Laboratories. Major updates paralleled recommendations from the Advisory Committee on Immunization Practices and schedule changes promulgated by the American Academy of Family Physicians. Collaborations included state immunization programs, academic epidemiologists from University of Michigan and University of Washington, and contractors such as private survey firms.

Key Findings and Coverage Estimates

Published estimates have documented identification of coverage disparities by geography, socioeconomic status, and race/ethnicity, highlighting gaps targeted by programs like Vaccines for Children Program and state initiatives in Texas and Florida. The survey has tracked uptake of vaccines including diphtheria–tetanus–pertussis, polio, hepatitis B, varicella, and human papillomavirus, informing policy debates in venues such as the U.S. Senate and state legislatures on school-entry requirements. Outputs have supported evaluation reports by the Centers for Medicare & Medicaid Services and influenced funding decisions at agencies like the Health Resources and Services Administration.

Data Quality and Limitations

Quality assessments note strengths including provider-verified vaccination histories and standardized weighting; limitations arise from nonresponse bias, changes in telephone usage patterns, and incomplete provider records. Methodological reports compare survey estimates with administrative counts from state immunization information systems such as those maintained by the Minnesota Department of Health and Georgia Department of Public Health, revealing potential underestimation or overestimation in specific subpopulations. External reviews by panels convened at National Academies of Sciences, Engineering, and Medicine have recommended methodological refinements and transparency in variance estimation.

Uses and Impact

Findings inform immunization policy, program evaluation, and outbreak response coordination involving entities such as the Association of State and Territorial Health Officials and the Infectious Diseases Society of America. Data underpin vaccine coverage targets in Healthy People initiatives, influence payer policy at organizations like Centers for Medicare & Medicaid Services, and guide educational campaigns by groups including the American Academy of Pediatrics and Parents of Vaccine-Preventable Disease advocacy organizations. The survey’s longitudinal estimates have been cited in peer-reviewed journals such as The New England Journal of Medicine and American Journal of Public Health.

International Comparisons and Variants Contribution

While focused on the United States, the survey’s methods have been referenced by international partners including the World Health Organization, the Pan American Health Organization, and Ministries of Health in countries such as Canada and Mexico for designing household immunization surveys. Comparable instruments like the Demographic and Health Survey and Multiple Indicator Cluster Survey provide global context for vaccine coverage measures; methodological exchanges have informed improvements in immunization information systems and survey practice across agencies like the European Centre for Disease Prevention and Control.

Category:Immunization surveillance Category:Public health in the United States